The Role of Autoimmunity and Obesity in Polycystic Ovary Syndrome

The Role of Autoimmunity and Obesity in Polycystic Ovary Syndrome

The goal of the study is to detect autoantibodies in the serum of the women with PCOS and evaluate the obesity markers to investigate the the role of autoimmunity and obesity in PCOS

Inclusion Criteria:

• patients diagnosed with PCOS according to the Rotterdam (2003) criteria.

Exclusion Criteria:

• Patients with other causes of hyperandrogenism as congenital adrenal hyperplasia, androgen-secreting tumors, Cushing's syndrome, hyperprolactinemia, virilizing ovarian or adrenal tumors and those taking drugs affecting insulin resistance, such as estrogens, oral contraceptives and corticosteroids during the previous three months before the study.